Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Undiagnosed Diseases Network, |
RCV000550163 | SCV000622146 | pathogenic | Rett syndrome, congenital variant | 2016-08-05 | criteria provided, single submitter | clinical testing | This terminating amino acid change (p.Y208X) has been reported in at least one affected individual (PMID 19578037). |
| Labcorp Genetics |
RCV000550163 | SCV001399979 | pathogenic | Rett syndrome, congenital variant | 2020-03-05 | criteria provided, single submitter | clinical testing | This sequence change results in a premature translational stop signal in the FOXG1 gene (p.Tyr208*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 282 amino acids of the FOXG1 protein. This variant is not present in population databases (ExAC no frequency). This nonsense change has been observed in individual(s) with clinical features of Rett syndrome (PMID: 28661489, 19578037). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 453289). For these reasons, this variant has been classified as Pathogenic. |
| NIHR Bioresource Rare Diseases, |
RCV001003977 | SCV001162003 | pathogenic | Global developmental delay; Axial hypotonia; Stereotypic movement disorder; Strabismus; Abnormal optic nerve morphology | no assertion criteria provided | research | ||
| Centre de Biologie Pathologie Génétique, |
RCV000550163 | SCV001427498 | pathogenic | Rett syndrome, congenital variant | 2019-01-01 | no assertion criteria provided | clinical testing |